Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019936626> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2019936626 endingPage "373" @default.
- W2019936626 startingPage "371" @default.
- W2019936626 abstract "Objective: to report the application of GPIIb/IIIa antagonist (Integrilin) in peri-percutaneous transluminal catheter angioplasty and stent implantation in Chinese. Method: Twenty-one patients who underwent percutaneous transluminal catheter angioplasty (PTCA) and stent implantation were included. After arterial puncture, integrilin was injected at dose of 180μg/kg, and then maintained at 2/μg/kg·min for 18 hours. Asprine, plavix(clopidogrel) and heparin were used at the same time. ACT, PT, KPTT and blood routine were routinely monitored. Results: All sheaths were drawn out 2 to 4 hours after the procedure., There was no severe complication such as hematoma, acute and subacute thrombosis in coronary artery, or thrombocytopenia. ACT returned to less than 150 seconds in 2 hours in 15 patients; in 4 hours in 6 patients. There was no significant difference between the pre- and post-procedure value of PT and platelet count. KPTT was significantly higher than pre-procedure value at 2 hours after the procedure. No recurrence of angina pectoris was observed in the first nine patients within one year follow-up, and no restenosis occurred in stents in the five patients who had coronary angiography one year later. Conclusion: Application of GPIIb/IIIa receptor antagonist (Integrilin) in peri-percutaneous transluminal catheter angioplasty and stent implantation in combination with aspirin and plavix could significantly reduce the dosage and duration of heparin with benefit of shortening the indwelling time of sheaths, but did not increase risk of bleeding or lead to thrombosis in stent." @default.
- W2019936626 created "2016-06-24" @default.
- W2019936626 creator A5027619452 @default.
- W2019936626 creator A5087944559 @default.
- W2019936626 date "2002-07-01" @default.
- W2019936626 modified "2023-09-24" @default.
- W2019936626 title "Application of GlycoProfein IIb/IIIa antagonist (Integrilin) in peri-percutaneous transluminal catheter angioplasty and stent implantation in Chinese" @default.
- W2019936626 cites W2077847621 @default.
- W2019936626 cites W2170352750 @default.
- W2019936626 cites W2408809997 @default.
- W2019936626 doi "https://doi.org/10.1007/bf03396470" @default.
- W2019936626 hasPublicationYear "2002" @default.
- W2019936626 type Work @default.
- W2019936626 sameAs 2019936626 @default.
- W2019936626 citedByCount "0" @default.
- W2019936626 crossrefType "journal-article" @default.
- W2019936626 hasAuthorship W2019936626A5027619452 @default.
- W2019936626 hasAuthorship W2019936626A5087944559 @default.
- W2019936626 hasConcept C141071460 @default.
- W2019936626 hasConcept C164705383 @default.
- W2019936626 hasConcept C2777557582 @default.
- W2019936626 hasConcept C2777785093 @default.
- W2019936626 hasConcept C2778283817 @default.
- W2019936626 hasConcept C2778583881 @default.
- W2019936626 hasConcept C2780326628 @default.
- W2019936626 hasConcept C2780813298 @default.
- W2019936626 hasConcept C2780868729 @default.
- W2019936626 hasConcept C2781267111 @default.
- W2019936626 hasConcept C42219234 @default.
- W2019936626 hasConcept C500558357 @default.
- W2019936626 hasConcept C71924100 @default.
- W2019936626 hasConceptScore W2019936626C141071460 @default.
- W2019936626 hasConceptScore W2019936626C164705383 @default.
- W2019936626 hasConceptScore W2019936626C2777557582 @default.
- W2019936626 hasConceptScore W2019936626C2777785093 @default.
- W2019936626 hasConceptScore W2019936626C2778283817 @default.
- W2019936626 hasConceptScore W2019936626C2778583881 @default.
- W2019936626 hasConceptScore W2019936626C2780326628 @default.
- W2019936626 hasConceptScore W2019936626C2780813298 @default.
- W2019936626 hasConceptScore W2019936626C2780868729 @default.
- W2019936626 hasConceptScore W2019936626C2781267111 @default.
- W2019936626 hasConceptScore W2019936626C42219234 @default.
- W2019936626 hasConceptScore W2019936626C500558357 @default.
- W2019936626 hasConceptScore W2019936626C71924100 @default.
- W2019936626 hasIssue "3" @default.
- W2019936626 hasLocation W20199366261 @default.
- W2019936626 hasOpenAccess W2019936626 @default.
- W2019936626 hasPrimaryLocation W20199366261 @default.
- W2019936626 hasRelatedWork W1992989545 @default.
- W2019936626 hasRelatedWork W2024610364 @default.
- W2019936626 hasRelatedWork W2057803163 @default.
- W2019936626 hasRelatedWork W2063199328 @default.
- W2019936626 hasRelatedWork W2075574631 @default.
- W2019936626 hasRelatedWork W2097970197 @default.
- W2019936626 hasRelatedWork W2155741325 @default.
- W2019936626 hasRelatedWork W2168494093 @default.
- W2019936626 hasRelatedWork W2323785475 @default.
- W2019936626 hasRelatedWork W2351026567 @default.
- W2019936626 hasRelatedWork W2363761616 @default.
- W2019936626 hasRelatedWork W2371580493 @default.
- W2019936626 hasRelatedWork W2384439564 @default.
- W2019936626 hasRelatedWork W2396513717 @default.
- W2019936626 hasRelatedWork W2413182531 @default.
- W2019936626 hasRelatedWork W2418070065 @default.
- W2019936626 hasRelatedWork W2985126699 @default.
- W2019936626 hasRelatedWork W3030501244 @default.
- W2019936626 hasRelatedWork W3149449117 @default.
- W2019936626 hasRelatedWork W2289463205 @default.
- W2019936626 hasVolume "3" @default.
- W2019936626 isParatext "false" @default.
- W2019936626 isRetracted "false" @default.
- W2019936626 magId "2019936626" @default.
- W2019936626 workType "article" @default.